Pathogenesis of experimental amyloid protein A amyloidosis in sore hocks-affected rabbits

References

• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med 2003;349:583–596.
   PubMed Web of Science ®Google Scholar
• Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD. A primer of amyloid nomenclature. Amyloid 2007;14:179–183.
   PubMed Web of Science ®Google Scholar
• Cray C, Zaias J, Altman NH. Acute phase response in animals: a review. Comp Med 2009;59:517–526.
   PubMed Web of Science ®Google Scholar
• Skinner M, Shirahama T, Benson MD, Cohen AS. Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest 1977;36:420–427.
   PubMed Web of Science ®Google Scholar
• Janigan DT, Druet RL. Experimental amyloidosis. Role of antigenicity and rapid induction. Am J Pathol 1966;48:1013–1025.
   PubMedGoogle Scholar
• McAdam KP, Sipe JD. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J Exp Med 1976;144:1121–1127.
   PubMed Web of Science ®Google Scholar
• Ram JS, Glener GG, DeLellis RA. Amyloid. I. Use of Freund’s adjuvant in experimental amyloidosis. Proc Soc Exp Biol Med 1968;127:854–856.
   PubMedGoogle Scholar
• Axelrad MA, Kisilevsky R, Willmer J, Chen SJ, Skinner M. Further characterization of amyloid-enhancing factor. Lab Invest 1982;47:139–146.
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Gruys E, Shirahama T. Does amyloid enhancing factor (AEF) exits? Is AEF a single biological entity? Amyloid 1995;2:128–133.
   Web of Science ®Google Scholar
• Johan K, Westermark G, Engström U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci U S A 1998;95:2558–2563.
   PubMed Web of Science ®Google Scholar
• Cui D, Kawano H, Takahashi M, Hoshii Y, Setoguchi M, Gondo T, Ishihara T. Acceleration of murine AA amyloidosis by oral administration of amyloid fibrils extracted from different species. Pathol Int 2002;52:40–45.
   PubMed Web of Science ®Google Scholar
• Jakob W. Spontaneous amyloidosis of mammals. Vet Pathol 1971;8:292–306.
   PubMed Web of Science ®Google Scholar
• Takahashi E, Kuwayama H, Kawamoto K, Matsui T, Inokuma H. Detection of serum amyloid A isoforms in cattle. J Vet Diagn Invest 2009;21:874–877.
   Google Scholar
• Fujinaga Y. Incidence of amyloid deposits in various organs in senile cows and their pathological characteristics [in Japanese with English abstract]. Yamaguchi Med J 1990;39:293–303.
   Google Scholar
• Tojo K, Tokuda T, Hoshii Y, Fu X, Higuchi K, Matsui T, Kametani F, Ikeda S. Unexpectedly high incidence of visceral AA-amyloidosis in slaughtered cattle in Japan. Amyloid 2005;12:103–108.
   PubMed Web of Science ®Google Scholar
• Yamada M, Kotani Y, Nakamura K, Kobayashi Y, Horiuchi N, Doi T, Suzuki S, Sato N, Kanno T, Matsui T. Immunohistochemical distribution of amyloid deposits in 25 cows diagnosed with systemic AA amyloidosis. J Vet Med Sci 2006;68:725–729.
   PubMed Web of Science ®Google Scholar
• Lundmark K, Westermark GT, Nyström S, Murphy CL, Solomon A, Westermark P. Transmissibility of systemic amyloidosis by a prion-like mechanism. Proc Natl Acad Sci U S A 2002;99:6979–6984.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cui D, Hoshii Y, Kawano H, Une Y, Gondo T, Ishihara T. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides. Scand J Immunol 2007;66:495–500.
   PubMed Web of Science ®Google Scholar
• Cui D, Kawano H, Hoshii Y, Liu Y, Ishihara T. Acceleration of murine AA amyloid deposition by bovine amyloid fibrils and tissue homogenates. Amyloid 2008;15:77–83.
   PubMed Web of Science ®Google Scholar
• Horiuchi N, Kotani Y, Koga M, Yamada M, Kobayashi Y, Matsui T. Experimental induction of amyloidosis by bovine amyloid fibrils in sore hock rabbits. Amyloid 2008;15:84–88.
   PubMed Web of Science ®Google Scholar
• Okerman L, Devriese LA, Maertens L, Okerman F, Godard C. Cutaneous staphylococcosis in rabbits. Vet Rec 1984;114:313–315.
   Google Scholar
• Pras M, Schubert M, Zucker-Franklin D, Rimon A, Franklin EC. The characterization of soluble amyloid prepared in water. J Clin Invest 1968;47:924–933.
   PubMed Web of Science ®Google Scholar
• Dias JL, Montau RJ. Staphylococcosis in captive exotic waterfowl. Avian Path 1994;23:659–669.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Dan C, Kawano H, Omoto M, Ishihara T. Pathological study on amyloidosis in Cygnus olor (mute swan) and other waterfowl. Med Mol Morphol 2008;41:99–108.
   PubMed Web of Science ®Google Scholar
• Westermark GT, Westermark P. Prion-like aggregates: infectious agent in human disease. Trends Mol Med 2010;16:501–507.
   PubMed Web of Science ®Google Scholar
• Röcken C, Shakespeare A. Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 2002;440:111–122.
   PubMed Web of Science ®Google Scholar
• Takahashi E, Uzuka Y, Tanabe S, Satoh M, Furuoka H. Serum amyloid A and haptoglobin levels in bovine amyloidosis. J Vet Med Sci 2007;69:321–323.
   Google Scholar
• Obici L, Raimondi S, Lavatelli F, Bellotti V, Merlini G. Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum 2009;61:1435–1440.
   PubMed Web of Science ®Google Scholar
• Pepys MB, Rademacher TW, Amatayakul-Chantler S, Williams P, Noble GE, Hutchinson WL, Hawkins PN, Nelson SR, Gallimore JR, Herbert J, et al. Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 1994;91:5602–5606.
   PubMed Web of Science ®Google Scholar